4FOX Ventures Early-stage healthcare and medtech investor with selective neurotech exposure in Switzerland and Asia.
Geneva, Switzerland ●
Venture capital
Action Potential Venture Capital GSK's corporate VC arm exclusively focused on bioelectronic medicines and peripheral neuromodulation devices.
Cambridge, United States ●
Corporate VC
Advanced Research and Invention Agency Providing non-dilutive government research funding for high-risk neurotechnology and scientific breakthroughs in the United Kingdom.
London, United Kingdom ●
Non-dilutive
Alumni Ventures Multi-stage VC network with broad portfolio including neurotech co-investments.
Manchester, United States ●
Venture capital
Alzheimer's Drug Discovery Foundation Dedicated Alzheimer's venture philanthropy funder supporting drugs, biomarkers, and diagnostics for neurodegeneration.
New York, United States ●
Non-dilutive
Amazon Alexa Fund Corporate fund backing AI, voice, ambient computing, and selected health technology startups.
Seattle, United States ●
Corporate VC
Amelia Armour Early-stage investor at Amadeus Capital focused on UK deep tech and healthcare.
Cambridge, United Kingdom ●
Angel investor
Ampersand Capital Partners Healthcare-focused growth PE with medtech and life sciences portfolio including neurodiagnostics.
Wellesley, United States ●
Venture capital
Amplitude Ventures Venture fund investing in precision medicine, medtech, and biotech from seed onward.
Montreal, Canada ●
Venture capital
Angelini Ventures Corporate VC of Angelini Industries with explicit strategic focus on brain health and neurological disorders.
Apollo Health Ventures Early-stage longevity and age-related disease investor with strong biotech focus.
Berlin, Germany ●
Venture capital
Arboretum Ventures VC investing in medtech and life sciences, including neuromodulation and neuro devices.
Ann Arbor, United States ●
Venture capital
ARCH Venture Partners VC investing in medtech and life sciences, including neuromodulation and neuro devices.
Chicago, United States ●
Venture capital
ARPA-H US government agency funding high-risk, high-reward biomedical breakthroughs including neurotechnology.
Washington D.C., United States ●
Non-dilutive
Autism Impact Fund Specialist impact investment fund backing companies developing technologies for autism.
San Francisco, United States ●
Venture capital
B Capital Group Major life sciences and deep-tech investor with exposure to BCI and neuroscience.
Manhattan Beach, United States ●
Venture capital
Bessemer Venture Partners Global multi-stage VC with broad healthcare and biotech portfolio including neurotech adjacencies.
Redwood City, United States ●
Venture capital
Beyond Next Ventures Japanese deep-tech VC with health and life science investments including neuroscience.
Tokyo, Japan ●
Venture capital
Bezos Expeditions Jeff Bezos’s investment vehicle backing transformative science and technology companies.
Mercer Island, United States ●
Family office
Bill & Melinda Gates Foundation Global philanthropic foundation with selective investment in neuroscience and neurological disease tools.
Seattle, United States ●
Venture capital
BioInnovation Institute Life sciences incubator and fund helping early research become venture-backed companies.
Copenhagen, Denmark ●
Accelerator/incubator
Blackstone Life Sciences World's largest life sciences private fund with a dedicated neuroscience portfolio company (Neurvati).
Cambridge, United States ●
Venture capital
BlueYard Capital Early-stage investor in frontier tech, biology, and decentralised systems.
Berlin, Germany ●
Venture capital
BOLD Capital Partners VC focused on exponential technologies, health, and deep science.
Santa Monica, United States ●
Venture capital
Brain Trust Accelerator Fund Early-stage investor focused on brain disease diagnostics and treatments.
Burlingame, United States ●
Venture capital
Breakout Ventures Seed investor in deep tech and science startups, including neurotech.
San Francisco, United States ●
Venture capital
Breyer Capital Global investor in frontier technology and life sciences across stages.
Austin, United States ●
Venture capital
Cambridge Innovation Capital VC backing deep tech and life sciences from the Cambridge ecosystem.
Cambridge, United Kingdom ●
Venture capital
Casdin Capital New York-based life sciences investment firm with $2B+ AUM investing across private and public healthcare and biotech.
New York, United States ●
Venture capital
Catalio Capital Management New York-based innovative healthcare investment firm with $2B AUM backing biomedical technology companies including neurotech.
New York, United States ●
Venture capital
Cedars-Sinai Accelerator Hospital-based accelerator providing clinical validation and seed funding to digital health and medtech startups.
Los Angeles, United States ●
Accelerator/incubator
Chaanakya Capital Early-stage investor focused on neurotech, neuromodulation, and medtech.
San Francisco, United States ●
Venture capital
Cochlear Hearing implant leader with strategic interest in neurotechnology and neural restoration.
Sydney, Australia ●
Corporate VC
Crane Venture Partners Early-stage VC backing deep tech, AI, and selected neuro/health platforms.
London, United Kingdom ●
Venture capital
Creative Destruction Lab Seed-stage program at the intersection of science and commerce, with active neurotech cohort.
Toronto, Canada ●
Accelerator/incubator
CureDuchenne Ventures Venture philanthropy fund supporting neuromuscular and related therapeutic innovation.
Newport Beach, United States ●
Other
Daphni French early-stage VC with health and deep-tech investments including neuroscience-adjacent companies.
Paris, France ●
Venture capital
DARPA US government agency funding breakthrough neurotechnology and advanced research.
Arlington, United States ●
Non-dilutive
Deep Science Ventures Venture studio creating science-based startups from pre-seed stage.
London, United Kingdom ●
Venture studio
Deerfield Management Healthcare-focused investment firm with public and private investments including neuromodulation.
New York, United States ●
Venture capital
DigiTx San Francisco-based venture capital firm that invests in early-stage digital health and neurotech companies using data science to deliver clinically validated treatments.
San Francisco, United States ●
Venture capital
Dolby Family Ventures Early-stage investor in neuroscience and life science platform companies.
San Francisco, United States ●
Family office
Draper Associates Early-stage deep-tech investor across AI, biotech, robotics, and frontier sectors.
San Mateo, United States ●
Venture capital
Eclipse Ventures Early-stage investor in physical-world technologies, including advanced healthcare systems.
Palo Alto, United States ●
Venture capital
Eli Lilly Pharma company with strategic investing across neuroscience and health technologies.
Indianapolis, United States ●
Corporate VC
European Innovation Council EU innovation body offering grants and equity to deep-tech startups.
Brussels, Belgium ●
Non-dilutive
European Investment Bank EU development bank providing loans, guarantees, and equity for deep-tech and health innovation in Europe.
Luxembourg, Luxembourg ●
Non-dilutive
Fifty Years VC Pre-seed deep-tech investor backing science startups solving major global problems.
San Francisco, United States ●
Venture capital
FONGIT Geneva incubator providing early support and funding to deep-tech startups.
Geneva, Switzerland ●
Accelerator/incubator
Forepont Capital Partners U.S.-based healthcare-focused investment firm that invests in growth-stage life sciences, medtech, and healthcare services companies.
New York, United States ●
Venture capital
Founders Fund Multi-stage venture fund backing frontier science, including neural interface companies.
San Francisco, United States ●
Venture capital
F-Prime Healthcare-focused VC investing from seed to growth in biotech and medtech.
Cambridge, United States ●
Venture capital
Gaingels Multi-stage venture fund backing frontier science, including neural interface companies.
Burlington, Vermont, United States ●
Other
General Catalyst Global venture firm investing from seed to growth in tech and healthcare.
San Francisco, United States ●
Venture capital
Gilde Healthcare European healthcare VC with Venture & Growth and Private Equity arms, with active neuroimaging investment.
Utrecht, Netherlands ●
Venture capital
Google Ventures Alphabet’s VC arm investing broadly in life sciences and advanced technology.
Mountain View, United States ●
Venture capital
GreyBird Ventures VC focused on diagnostics and precision medicine technologies.
Concord, United States ●
Venture capital
Hatteras Venture Partners Early-stage healthcare VC investing in biotech, medtech, and neuroscience companies.
Durham, United States ●
Venture capital
Health Innovation Hub Ireland Irish innovation hub helping health startups validate products in care settings.
Dublin, Ireland ●
Accelerator/incubator
High-Tech Gründerfonds Germany’s leading seed investor in deep tech, life sciences, and medtech.
Bonn, Germany ●
Venture capital
Hikma Ventures Corporate venture investor focused on digital health and care delivery platforms.
London, United Kingdom ●
Corporate VC
imec.xpand Deep-tech investor focused on semiconductors, sensors, and health technologies.
Leuven, Belgium ●
Corporate VC
Imperial Innovation Fund Fund commercialising Imperial College research into science and tech companies.
London, United Kingdom ●
Other
Indaco Venture Partners Italian VC investing in medtech, biotech, robotics, and electronics.
Milan, Italy ●
Venture capital
IndieBio (SOSV) Leading biotech accelerator and pre-seed investor with neurotech exposure.
San Francisco, United States ●
Accelerator/incubator
InHealth Ventures UK healthtech VC with investments in digital health and brain health innovation.
London, United Kingdom ●
Venture capital
INKEF Capital European VC backing early-stage healthcare and technology companies.
Amsterdam, Netherlands ●
Venture capital
Innogest Capital Italian early-stage VC with investments in medtech and digital health including neurotech-adjacent companies.
Turin, Italy ●
Venture capital
Innovate UK European VC backing early-stage healthcare and technology companies.
London, United Kingdom ●
Non-dilutive
Innoviva Specialty Therapeutics Diversified biopharmaceutical company making strategic healthcare investments including a $17.5M stake in Beacon Biosignals.
Burlingame, United States ●
Corporate VC
In-Q-Tel Strategic investor supporting frontier technologies relevant to US agencies.
Tysons, United States ●
Other
Invest-NL Dutch national development finance institution investing in deeptech and health innovation.
Amsterdam, Netherlands ●
Non-dilutive
Invus Global long-duration investment firm with flexible capital across healthcare and life sciences.
New York, United States ●
Private equity/growth
IP Group Publicly listed investor commercialising university spin-outs in science and deep tech.
London, United Kingdom ●
Venture capital
JAZZ Venture Partners Specialist VC at the intersection of neuroscience and human performance technology.
San Francisco, United States ●
Venture capital
Johnson & Johnson Development Corporation J&J's strategic CVC arm with active investments across medtech including neuromodulation.
New Brunswick, United States ●
Corporate VC
Jolt Capital European deep-tech growth VC with semiconductor and advanced technology investments.
Paris, France ●
Venture capital
Joyance Partners Multi-stage VC with a dedicated neurotech and brain interface investment thesis.
San Francisco, United States ●
Venture capital
JSL Health Capital Washington DC-based investment firm and venture studio focused on healthcare companies leveraging AI, data, and software.
Washington D.C., United States ●
Venture capital
Kaleida Capital Early-stage investor focused on brain health and neurotechnology.
San Diego, United States ●
Venture capital
Khosla Ventures Multi-stage VC with a dedicated neurotech and brain interface investment thesis.
Menlo Park, United States ●
Venture capital
Kicker Ventures Menlo Park-based early-stage VC investing in healthcare technology with a focus on US and Japanese market fit.
Menlo Park, United States ●
Venture capital
Kickfund Basel-based venture capital firm that provides systematic follow-on funding to high-tech Swiss startups that have successfully graduated from the Venture Kick accelerator program.
Basel, Switzerland ●
Venture capital
Kizoo Technology Capital Seed investor in rejuvenation biotech and frontier biological technologies.
Karlsruhe, Germany ●
Venture capital
Kurma Partners European biotech VC with investments in neurology, neurodegeneration, and diagnostics.
Paris, France ●
Venture capital
LifeArc Ventures Venture arm of LifeArc backing early science-led biotech and healthtech companies.
London, United Kingdom ●
Venture capital
Lightspeed Venture Partners Global VC investing across stages in technology and healthcare.
Menlo Park, United States ●
Venture capital
LionBird Ventures Global VC investing across stages in technology and healthcare.
Tel Aviv, Israel ●
Venture capital
Logos Capital San Francisco-based biotech-focused hedge fund and investor using data-driven clinical trial analysis.
San Francisco, United States ●
Venture capital
LongevityTech.fund Early-stage fund focused on longevity, biomarkers, and neuro-ageing technologies.
Boca Raton, United States ●
Venture capital
Longitude Capital Growth-oriented healthcare VC focused on clinically validated companies.
Menlo Park, United States ●
Venture capital
Lux Capital Deep-tech investor backing frontier science, including BCI and neural interfaces.
New York, United States ●
Venture capital
Manta Ray Ventures Early-stage VC backing mission-driven science and neurotech-adjacent startups.
London, United Kingdom ●
Venture capital
MedTech Innovator MedTech accelerator and competition platform supporting medical device and neurotech companies.
Los Angeles, United States ●
Accelerator/incubator
Menlo Ventures Multi-stage US VC with healthcare and AI investments including digital mental health.
Menlo Park, United States ●
Venture capital
METIS Innovative Seed investor focused on neurodevices, neuromodulation, and pain technologies.
Miami Beach, United States ●
Venture capital
Michael J. Fox Foundation World's largest nonprofit Parkinson's research funder using venture philanthropy to advance therapeutic development.
New York, United States ●
Non-dilutive
Mission BioCapital Early-stage life sciences investor with lab space and venture support.
Cambridge, United States ●
Venture capital
Morningside Ventures Life sciences and medtech investor with notable neurotechnology exposure.
Newton Center, United States ●
Venture capital
.svg)
.svg)
.svg)
